Shanghai Iluvatar CoreX Semiconductor revenue and financials
In the fiscal year ended December 2025, Shanghai Iluvatar CoreX Semiconductor reported revenue of ¥1.03B (+91.58% year over year). The net loss was ¥1B.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +91.58%
- 2025 vs 2024
- Net margin
- -97.1%
- 2024: -165.4%
How Shanghai Iluvatar CoreX Semiconductor is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 76.1% a year on average over the last 3 years
Compound annual growth rate: from ¥189.37M in 2022 to ¥1.03B in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −305.2% to −102.9%
Operating income over revenue, 2022 → 2025: 202.3 percentage points.
Shares outstanding up 43.9% in 3 years
Average diluted shares, 2022 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 0 of 4 fiscal years
Positive net income, fiscal years 2022–2025.
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 1,034 | 540 | 289 | 189 |
| Cost of revenue | 476 | 274 | 146 | 77.0 |
| Gross profit | 558 | 265 | 143 | 112 |
| Selling, general and administrative | 633 | 380 | 330 | 215 |
| Research and development | 974 | 773 | 616 | 457 |
| Operating income | -1,064 | -919 | -825 | -578 |
| EBIT | -1,064 | -919 | -825 | -578 |
| EBITDA | -944 | -811 | -745 | -512 |
| Interest expense | 20.6 | 17.4 | 11.0 | 6.5 |
| Pre-tax income | -1,004 | -892 | -817 | -554 |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | -1,004 | -892 | -791 | -524 |
| Net income to common shareholders | -1,004 | -892 | -791 | -524 |
| Basic EPS | -1.77 | -1.82 | -1.81 | -1.33 |
| Diluted EPS | -1.77 | -1.82 | -1.81 | -1.33 |
| Average shares (basic) | 567 | 491 | 438 | 394 |
| Average shares (diluted) | 567 | 491 | 438 | 394 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Total revenue | 946 | 709 | 324 | 342 | 197 |
| Cost of revenue | 783 | 314 | 162 | 166 | 108 |
| Gross profit | 163 | 396 | 162 | 176 | 89.0 |
| Selling, general and administrative | 241 | 291 | 342 | 206 | 174 |
| Research and development | 559 | 523 | 451 | 439 | 334 |
| Operating income | -648 | -431 | -633 | -491 | -428 |
| EBIT | -648 | -431 | -633 | -491 | -428 |
| EBITDA | -544 | -371 | -554 | -446 | -364 |
| Interest expense | 20.3 | 9.5 | 11.1 | 9.0 | 8.4 |
| Pre-tax income | 106 | -394 | -609 | -488 | -404 |
| Net income | 106 | -394 | -609 | -488 | -404 |
| Net income to common shareholders | 106 | -394 | -609 | -488 | -404 |
| Basic EPS | 0.15 | -0.65 | -1.16 | -0.99 | -0.83 |
| Diluted EPS | 0.14 | -0.65 | -1.16 | -0.99 | -0.83 |
| Average shares (basic) | 725 | 608 | 526 | 495 | 488 |
| Average shares (diluted) | 745 | 608 | 526 | 495 | 488 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | 3,912 | 1,685 | 1,593 | 1,047 |
| Current assets | 3,432 | 1,262 | 1,287 | 785 |
| Cash and equivalents | 1,505 | 314 | 308 | 219 |
| Short-term investments | 38.9 | 49.0 | 4.8 | 33.9 |
| Receivables | 620 | 453 | 546 | 111 |
| Inventory | 710 | 343 | 233 | 244 |
| Net property, plant and equipment | 198 | 169 | 114 | 102 |
| Other intangible assets | 190 | 141 | 74.6 | 101 |
| Long-term investments | 76.9 | 97.4 | 91.3 | 50.0 |
| Current liabilities | 1,112 | 880 | 686 | 317 |
| Accounts payable | 31.1 | 45.6 | 18.2 | 85.3 |
| Long-term debt | 365 | 42.0 | 0.0 | 50.0 |
| Total debt | 534 | 101 | 110 | 65.8 |
| Total liabilities | 1,559 | 997 | 715 | 427 |
| Total equity (incl. minority) | 2,353 | 689 | 878 | 620 |
| Retained earnings | -1,684 | -3,743 | -2,851 | -2,059 |
| Minority interest | — | 0.0 | -44.4 | -41.3 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Total assets | 9,801 | 3,912 | 3,561 | 1,685 | — |
| Current assets | 9,100 | 3,432 | 3,172 | 1,262 | — |
| Cash and equivalents | 2,911 | 1,505 | 1,713 | 314 | — |
| Short-term investments | 182 | 38.9 | 39.9 | 49.0 | — |
| Receivables | 1,240 | 620 | 438 | 453 | — |
| Inventory | 1,968 | 710 | 495 | 343 | — |
| Net property, plant and equipment | 288 | 198 | 146 | 169 | — |
| Other intangible assets | 188 | 190 | 142 | 141 | — |
| Long-term investments | 122 | 76.9 | 96.8 | 97.4 | — |
| Current liabilities | 2,453 | 1,112 | 876 | 880 | — |
| Accounts payable | 827 | 31.1 | 29.9 | 45.6 | — |
| Long-term debt | 1,402 | 365 | 83.5 | 42.0 | — |
| Total debt | 2,713 | 534 | 149 | 101 | — |
| Total liabilities | 4,001 | 1,559 | 1,045 | 997 | — |
| Total equity (incl. minority) | 5,800 | 2,353 | 2,516 | 689 | — |
| Retained earnings | -1,578 | -1,684 | -1,290 | -3,743 | — |
| Minority interest | — | — | 0.0 | — | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -1,162 | -618 | -707 | -654 |
| Depreciation and amortization | 137 | 124 | 93.6 | 76.5 |
| Capital expenditure | -103 | -84.8 | -70.7 | -82.2 |
| Investing cash flow | -132 | -166 | -153 | -183 |
| Financing cash flow | 2,491 | 789 | 946 | 953 |
| Share repurchases | -1.2 | -14.8 | 0.0 | 0.0 |
| Debt issued | 1,070 | 730 | 498 | 204 |
| Debt repaid | -700 | -634 | -123 | -155 |
| Effect of exchange rates | -5.9 | 0.0 | 2.8 | 7.3 |
| Net change in cash | 1,191 | 5.5 | 88.7 | 124 |
| Free cash flow | -1,264 | -703 | -778 | -736 |
| Levered free cash flow | -1,001 | -180 | -786 | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Operating cash flow | -2,786 | -446 | -716 | -71.6 | -546 |
| Depreciation and amortization | 111 | 66.1 | 90.3 | 54.2 | 69.4 |
| Capital expenditure | -242 | -79.0 | -23.5 | -42.9 | -41.9 |
| Investing cash flow | -651 | -81.1 | -51.2 | -79.3 | -86.6 |
| Financing cash flow | 4,858 | 323 | 2,168 | 161 | 629 |
| Share repurchases | — | -3.3 | -1.2 | -12.9 | -1.9 |
| Debt issued | 2,000 | 648 | 422 | 330 | 400 |
| Debt repaid | -332 | -313 | -388 | -246 | -388 |
| Effect of exchange rates | -15.5 | -4.3 | -1.6 | — | — |
| Net change in cash | 1,406 | -208 | 1,400 | 9.5 | -4.0 |
| Free cash flow | -3,028 | -525 | -739 | -115 | -588 |
| Levered free cash flow | -3,076 | -460 | -541 | -180 | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
